Insights into asthmatic airway remodelling through murine models

Respirology

Volumn 16, Issue 4, 2011, Pages 589-597

  Al Heialy, Saba ^a   McGovern, Toby K ^a   Martin, James G ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

airway smooth muscle; cysteinyl leukotriene; epidermal growth factor; goblet cell; inflammatory cell; interleukins

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; MATRIX METALLOPROTEINASE; PEPTIDOLEUKOTRIENE;

ASTHMA; BONE MARROW TRANSPLANTATION; DISEASE MODEL; EOSINOPHIL; HUMAN; MACROPHAGE; MAST CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

AIRWAY REMODELING; ALLERGENS; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; EOSINOPHILS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; MACROPHAGES; MAST CELLS; MATRIX METALLOPROTEINASES; MICE; NEUTROPHILS; RATS; T-LYMPHOCYTES; TH17 CELLS;

EID: 79955437252     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.01974.x     Document Type: Review

References (79)

1. Dunnill MS, Masarrella GR, Anderson JA,. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis and in emphysema. Thorax 1969; 24: 176-9.
2. Lambert RK, Wiggs BR, Kuwano K, et al,. Functional significance of increased airway smooth muscle in asthma and COPD. J. Appl. Physiol. 1993; 74: 2771-81. (Pubitemid 23201305)
3. Sapienza S, Du T, Eidelman DH, et al,. Structural changes in the airways of sensitized brown Norway rats after antigen challenge. Am. Rev. Respir. Dis. 1991; 144: 423-7.
4. Salmon M, Walsh DA, Koto H, et al,. Repeated allergen exposure of sensitized Brown-Norway rats induces airway cell DNA synthesis and remodelling. Eur. Respir. J. 1999; 14: 633-41. (Pubitemid 29479731)
5. Blanc PD, Cisternas M, Smith S, et al,. Occupational asthma in a community-based survey of adult asthma. Chest 1996; 109: 56S-7S.
6. Takeda N, Maghni K, Daigle S, et al,. Long-term pathologic consequences of acute irritant-induced asthma. J Allergy Clin. Immunol. 2009; 124: 975-81.
7. Rachiotis G, Savani R, Brant A, et al,. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 2007; 62: 147-52.
8. Demnati R, Fraser R, Plaa G, et al,. Histopathological effects of acute exposure to chlorine gas on Sprague-Dawley rat lungs. J. Environ. Pathol. Toxicol. Oncol. 1995; 14: 15-19.
9. Martin JG, Campbell HR, Iijima H, et al,. Chlorine-induced injury to the airways in mice. Am. J. Respir. Crit. Care Med. 2003; 168: 568-74. (Pubitemid 37088600)
10. Leustik M, Doran S, Bracher A, et al,. Mitigation of chlorine-induced lung injury by low-molecular-weight antioxidants. Am. J. Physiol. Lung Cell Mol. Physiol. 2008; 295: L733-43.
11. Tuck SA, Ramos-Barbon D, Campbell H, et al,. Time course of airway remodelling after an acute chlorine gas exposure in mice. Respir. Res. 2008; 9: 2772-80.
12. Zarogiannis SG, Jurkuvenaite A, Fernandez S, et al,. Ascorbate and Deferoxamine Administration Post Chlorine Exposure Decrease Mortality and Lung Injury in Mice. Am. J. Respir. Cell Mol. Biol. 2010; doi:10.1165/rcmb.2010- 0432OC.
13. Maes T, Provoost S, Lanckacker EA, et al,. Mouse models to unravel the role of inhaled pollutants on allergic sensitization and airway inflammation. Respir. Res. 2010; doi:10.1186/1465-9921-11-7.
14. Balmes JR,. How does diesel exhaust impact asthma? Thorax 2011; 66: 4-6.
15. Maejima K, Tamura K, Nakajima T, et al,. Effects of the inhalation of diesel exhaust, Kanto loam dust, or diesel exhaust without particles on immune responses in mice exposed to Japanese cedar (Cryptomeria japonica) pollen. Inhal. Toxicol. 2001; 13: 1047-63. (Pubitemid 33107835)
16. Okayama Y, Ra C, Saito H,. Role of mast cells in airway remodeling. Curr. Opin. Immunol. 2007; 19: 687-93. (Pubitemid 350236804)
17. Brightling CE, Bradding P, Symon FA, et al,. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 2002; 346: 1699-705. (Pubitemid 34547483)
18. Bradding P, Holgate ST,. The mast cell as a source of cytokines in asthma. Ann. N. Y. Acad. Sci. 1996; 796: 272-81. (Pubitemid 26405438)
19. Bradding P, Walls AF, Holgate ST,. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 2006; 117: 1277-84. (Pubitemid 43795741)
20. Okayama Y, Okumura S, Sagara H, et al,. FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells. Eur. Respir. J. 2009; 34: 425-35.
21. Hollins F, Kaur D, Yang W, et al,. Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6. J. Immunol. 2008; 181: 2772-80.
22. Yu M, Tsai M, Tam SY, et al,. Mast cells can promote the development of multiple features of chronic asthma in mice. J. Clin. Invest. 2006; 116: 1633-41.
23. Kearley J, Erjefalt JS, Andersson C, et al,. IL-9 Governs Allergen-induced Mast Cell Numbers in the Lung and Chronic Remodeling of the Airways. Am. J. Respir. Crit. Care Med. 2010; 183: 865-75.
24. Cho JY, Miller M, Baek KJ, et al,. Inhibition of airway remodeling in IL-5-deficient mice. J. Clin. Invest. 2004; 113: 551-60. (Pubitemid 38542504)
25. Ochkur SI, Jacobsen EA, Protheroe CA, et al,. Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. J. Immunol. 2007; 178: 7879-89. (Pubitemid 46898060)
26. Humbles AA, Lloyd CM, McMillan SJ, et al,. A critical role for eosinophils in allergic airways remodeling. Science 2004; 305: 1776-9. (Pubitemid 39249645)
27. Komai M, Tanaka H, Nagao K, et al,. A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial/ peribronchial fibrosis induced by repeated antigen challenge in mice. J. Pharmacol. Sci. 2010; 112: 203-13.
28. Fattouh R, Al-Garawi A, Fattouh M, et al,. Eosinophils Are Dispensable for Allergic Remodeling and Immunity in a Model of House Dust Mite-induced Airway Disease. Am. J. Respir. Crit. Care Med. 2011; 183: 179-88.
29. Kumar RK, Herbert C, Yang M, et al,. Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin. Exp. Allergy 2002; 32: 1104-11. (Pubitemid 34779610)
30. Le AV, Cho JY, Miller M, et al,. Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice. J. Immunol. 2007; 178: 7310-16. (Pubitemid 46847458)
31. Goldsmith AM, Bentley JK, Zhou L, et al,. Transforming growth factor-beta induces airway smooth muscle hypertrophy. Am. J. Respir. Cell Mol. Biol. 2006; 34: 247-54. (Pubitemid 43202473)
32. Macdowell AL, Peters SP,. Neutrophils in asthma. Curr. Allergy Asthma Rep. 2007; 7: 464-8. (Pubitemid 47629081)
33. Sur S, Crotty TB, Kephart GM, et al,. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 1993; 148: 713-19. (Pubitemid 23263785)
34. Mazaki Y, Hashimoto S, Tsujimura T, et al,. Neutrophil direction sensing and superoxide production linked by the GTPase-activating protein GIT2. Nat. Immunol. 2006; 7: 724-31. (Pubitemid 43905871)
35. Wilson RH, Whitehead GS, Nakano H, et al,. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2009; 180: 720-30.
36. Brusselle GG, Kips JC, Tavernier JH, et al,. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy 1994; 24: 73-80. (Pubitemid 24210819)
37. Foster PS, Yang M, Herbert C, et al,. CD4(+) T-lymphocytes regulate airway remodeling and hyper-reactivity in a mouse model of chronic asthma. Lab. Invest. 2002; 82: 455-62. (Pubitemid 34311117)
38. Lazaar AL, Albelda SM, Pilewski JM, et al,. T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J. Exp. Med. 1994; 180: 807-16. (Pubitemid 24256594)
39. Ramos-Barbon D, Presley JF, Hamid QA, et al,. Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma. J. Clin. Invest. 2005; 115: 1580-9. (Pubitemid 40814666)
40. Wang Q, Li H, Yao Y, et al,. The overexpression of heparin-binding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model. J. Immunol. 2010; 185: 834-41.
41. Doherty TA, Soroosh P, Broide DH, et al,. CD4+ cells are required for chronic eosinophilic lung inflammation but not airway remodeling. Am. J. Physiol. Lung Cell Mol. Physiol. 2009; 296: L229-35.
42. Tsuchiya K, Isogai S, Tamaoka M, et al,. Depletion of CD8+ T cells enhances airway remodelling in a rodent model of asthma. Immunology 2009; 126: 45-54.
43. Careau E, Bissonnette EY,. Adoptive transfer of alveolar macrophages abrogates bronchial hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 2004; 31: 22-7. (Pubitemid 38888035)
44. Careau E, Turmel V, Lauzon-Joset JF, et al,. Alveolar macrophages reduce airway hyperresponsiveness and modulate cytokine levels. Exp. Lung Res. 2010; 36: 255-61.
45. Herbert C, Scott MM, Scruton KH, et al,. Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma. Am. J. Pathol. 2010; 177: 1657-64.
46. Yum HY, Cho JY, Miller M, et al,. Allergen-Induced Coexpression of bFGF and TGF-beta1 by Macrophages in a Mouse Model of Airway Remodeling: bFGF Induces Macrophage TGF-beta1 Expression in vitro. Int. Arch. Allergy Immunol. 2010; 155: 12-22.
47. Zhu Z, Homer RJ, Wang Z, et al,. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 1999; 103: 779-88. (Pubitemid 29152623)
48. Tomlinson KL, Davies GC, Sutton DJ, et al,. Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite. PLoS ONE 2010; 5: e13136.
49. Bergeron C, Page N, Barbeau B, et al,. Interleukin-4 promotes airway remodeling in asthma: regulation of procollagen I (alpha1) gene by interleukin-4. Chest 2003; 123: 424S. (Pubitemid 36315444)
50. Rankin JA, Picarella DE, Geba GP, et al,. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. USA 1996; 93: 7821-5. (Pubitemid 26277122)
51. Leigh R, Ellis R, Wattie JN, et al,. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am. J. Respir. Crit. Care Med. 2004; 169: 860-7. (Pubitemid 38402464)
52. Chan HW, Smith NJ, Hannan RD, et al,. Tackling the EGFR in pathological tissue remodelling. Pulm. Pharmacol. Ther. 2006; 19: 74-8. (Pubitemid 41606856)
53. Takeyama K, Dabbagh K, Lee HM, et al,. Epidermal growth factor system regulates mucin production in airways. Proc. Natl. Acad. Sci. USA 1999; 96: 3081-6. (Pubitemid 29148847)
54. Tamaoka M, Hassan M, McGovern T, et al,. The epidermal growth factor receptor mediates allergic airway remodelling in the rat. Eur. Respir. J. 2008; 32: 1213-23.
55. Vargaftig BB, Singer M,. Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR. Am. J. Physiol. Lung Cell Mol. Physiol. 2003; 285: L808-18. (Pubitemid 37158827)
56. Hur GY, Lee SY, Lee SH, et al,. Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation. Exp. Mol. Med. 2007; 39: 367-75.
57. Hassan M, Jo T, Risse PA, et al,. Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma. J Allergy Clin. Immunol. 2010; 125: 1037-45.
58. Kramer EL, Mushaben EM, Pastura PA, et al,. Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice. Am. J. Respir. Cell Mol. Biol. 2009; 41: 415-25.
59. Bosse M, Chakir J, Rouabhia M, et al,. Serum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am. J. Respir. Crit. Care Med. 1999; 159: 596-602. (Pubitemid 29084886)
60. Cho JY, Miller M, McElwain K, et al,. Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: modulation by immunostimulatory DNA. J. Allergy Clin. Immunol. 2006; 117: 618-25. (Pubitemid 43340227)
61. Lim DH, Cho JY, Miller M, et al,. Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice. Am. J. Physiol. Lung Cell Mol. Physiol. 2006; 291: L265-71. (Pubitemid 44148111)
62. Jie Z, Jin M, Cai Y, et al,. The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation. Respir. Physiol. Neurobiol. 2009; 168: 289-94.
63. Knolle MD, Owen CA,. ADAM8: a new therapeutic target for asthma. Expert Opin. Ther. Targets 2009; 13: 523-40.
64. Van EP, Little RD, Dupuis J, et al,. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002; 418: 426-30. (Pubitemid 34826843)
65. Howard TD, Postma DS, Jongepier H, et al,. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J. Allergy Clin. Immunol. 2003; 112: 717-22. (Pubitemid 37260387)
66. Werner M, Herbon N, Gohlke H, et al,. Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin. Exp. Allergy 2004; 34: 26-31. (Pubitemid 38183676)
67. van Diemen CC, Postma DS, Vonk JM, et al,. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am. J. Respir. Crit. Care Med. 2005; 172: 329-33. (Pubitemid 41026143)
68. Puxeddu I, Pang YY, Harvey A, et al,. The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma. J. Allergy Clin. Immunol. 2008; 121: 1400-6.
69. Austen KF,. The cysteinyl leukotrienes: where do they come from? What are they? Where are they going? Nat. Immunol. 2008; 9: 113-15.
70. Kanaoka Y, Boyce JA,. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 2004; 173: 1503-10. (Pubitemid 38971578)
71. Henderson WR Jr, Lewis DB, Albert RK, et al,. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J. Exp. Med. 1996; 184: 1483-94. (Pubitemid 26354703)
72. Henderson WR Jr, Tang LO, Chu SJ, et al,. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 2002; 165: 108-16. (Pubitemid 34053366)
73. Wang CG, Du T, Xu LJ, et al,. Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat. Am. Rev. Respir. Dis. 1993; 148: 413-17. (Pubitemid 23221587)
74. Salmon M, Walsh DA, Huang TJ, et al,. Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats. Br. J. Pharmacol. 1999; 127: 1151-8. (Pubitemid 29326638)
75. Henderson WR Jr, Chiang GK, Tien YT, et al,. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am. J. Respir. Crit. Care Med. 2006; 173: 718-28.
76. Bonfield TL, Koloze M, Lennon DP, et al,. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am. J. Physiol. Lung Cell Mol. Physiol. 2010; 299: L760-70.
77. Nemeth K, Keane-Myers A, Brown JM, et al,. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc. Natl. Acad. Sci. USA 2010; 107: 5652-7.
78. Kearley J, Robinson DS, Lloyd CM,. CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J. Allergy Clin. Immunol. 2008; 122: 617-24.
79. McGovern TK, Powell WS, Day BJ, et al,. Dimethylthiourea protects against chlorine induced changes in airway function in a murine model of irritant induced asthma. Respir. Res. 2010; 11: 113-15.